Sun Pharma Advanced Research Company Limited (SPARC) — Capital Reinvestment Ratio
Sun Pharma Advanced Research Company Limited (SPARC) has a Capital Reinvestment Ratio of 0.79x as of September 2023, meaning it reinvests 1% of its operating cash flow (Rs63.60 Million) in capital expenditures (Rs50.40 Million). See how leveraged is Sun Pharma Advanced Research Company Lim's balance sheet to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Sun Pharma Advanced Research Company Limited Capital Reinvestment Ratio (2009–2014)
This chart tracks Sun Pharma Advanced Research Company Limited's Capital Reinvestment Ratio across 4 annual periods. Check total reinvestment intensity of Sun Pharma Advanced Research Company Lim to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Sun Pharma Advanced Research Company Limited (2009–2014)
Year-by-year Capital Reinvestment Ratio for Sun Pharma Advanced Research Company Limited from 2009 to 2014. For live market cap and broader valuation context, see Sun Pharma Advanced Research Company Lim (SPARC) total market value.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2014 | 0.10x | Rs368.95 Million | Rs36.74 Million | ▼ -94.7% |
| 2011 | 1.89x | Rs25.05 Million | Rs47.34 Million | ▲ +191.8% |
| 2010 | 0.65x | Rs126.34 Million | Rs81.83 Million | ▼ -37.2% |
| 2009 | 1.03x | Rs254.54 Million | Rs262.35 Million | — |